14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.83 $2.51 Thursday, 2nd May 2024 CGEN stock ended at $2.16. This is 8.54% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 8.37% from a day low at $2.03 to a day high of $2.20.
90 days $1.83 $3.03
52 weeks $0.530 $3.03

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Jul 23, 2020 $14.98 $15.60 $14.51 $14.63 985 638
Jul 22, 2020 $16.00 $16.01 $15.10 $15.27 1 372 600
Jul 21, 2020 $16.92 $17.11 $16.01 $16.04 1 245 400
Jul 20, 2020 $16.17 $16.95 $15.67 $16.85 1 247 300
Jul 17, 2020 $15.22 $16.25 $15.00 $16.01 1 046 300
Jul 16, 2020 $15.51 $15.51 $14.82 $14.87 953 400
Jul 15, 2020 $14.85 $15.81 $14.65 $15.52 1 433 400
Jul 14, 2020 $14.65 $15.15 $13.80 $14.57 1 845 700
Jul 13, 2020 $15.90 $16.92 $14.86 $14.97 1 753 900
Jul 10, 2020 $16.45 $16.69 $15.78 $15.86 738 600
Jul 09, 2020 $16.06 $16.47 $15.70 $16.28 910 300
Jul 08, 2020 $15.98 $16.25 $15.58 $15.93 921 000
Jul 07, 2020 $15.31 $16.43 $15.11 $15.82 1 098 000
Jul 06, 2020 $15.17 $16.00 $15.17 $15.46 1 019 400
Jul 02, 2020 $15.00 $15.74 $14.72 $15.40 893 582
Jul 01, 2020 $15.01 $15.18 $14.22 $14.74 1 202 126
Jun 30, 2020 $14.11 $15.10 $13.99 $15.02 1 045 481
Jun 29, 2020 $14.47 $14.75 $13.78 $14.04 1 021 352
Jun 26, 2020 $15.03 $15.40 $14.45 $14.59 878 892
Jun 25, 2020 $14.95 $15.35 $14.52 $15.03 652 917
Jun 24, 2020 $15.74 $16.33 $14.66 $14.88 1 591 882
Jun 23, 2020 $16.84 $17.15 $16.12 $16.21 1 468 780
Jun 22, 2020 $15.50 $16.74 $15.40 $16.48 1 420 192
Jun 19, 2020 $15.58 $16.25 $15.33 $15.53 1 114 889
Jun 18, 2020 $14.92 $15.70 $14.84 $15.42 694 295
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT